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Abstract 
Background 
Atrioventricular septal defect (AVSD) has an incidence of 4-5.3 per 10.000 live births and is associated 
with Down syndrome (DS). Data on arrhythmias and sudden cardiac death (SCD) after AVSD 
correction is scarce.  
Aim 
To analyse the incidence of post-operative arrhythmias and SCD after AVSD correction and explore 
risk factors. 
Methods  
This is a retrospective multicenter study including patients after biventricular AVSD correction. 
Univariate and multivariate analyses were performed to explore risk factors. 
Results 
A total of 415 patients were included with a mean follow-up duration of 9 years (range; <30 days – 47 
years).  
Early post-operative SVTs were documented in 33 patients (8%) and late post-operative SVTs in 15 
patients (3.6%). Non-syndromic AVSD (p=0.022, HR=2.64; 95% CI= 1.15-6.04) and cAVSD (p=0.005, 
HR= 3.7; 95% CI= 1.39-7.51) were independent risk factors for early post-operative SVTs and 
significant more late post-operative SVTs occurred in non-syndromic patients (p=0.016, HR=6.38; 
95% CI= 1.42-28.71) and in pAVSD (p=0.045, HR=3.703; 95% CI= 1.03-13.32). Fifteen patients (3.6%) 
received a pacemaker. Non-syndromic AVSD (p=0.008, HR=15.82; 95% CI= 2.04-122.47), pAVSD 
(p=0.017, HR=6.26; 95% CI= 1.39-28.28) and re-operation (p=0.007, HR=4.911; 95% CI= 1.54-15.64) 
were independent risk factors for postoperative pacemaker implantation. 
Late life-threatening ventricular arrhythmias and SCD occurred in 0.5% and 1.7% respectively. 
 
Conclusion 
There is good long-term survival after AVSD correction and incidence of SCD is low. Non-syndromic 
AVSD and cAVSD are independent risk factors for early post-operative SVTs. Non-syndromic AVSD 
patients have significant more early 3rd degree AVB and late post-operative SVTs. Non-syndromic 
patients with partial AVSD who have undergone reoperation have a significant higher risk of 
pacemaker implantation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Atrioventricular septal defect (AVSD) represents a spectrum of cardiac anomalies characterized by 
incomplete development of the atrioventricular septum along with abnormalities of the 
atrioventricular (AV) valves. The incidence of AVSD is 4-5.3 per 10.000 live births and it is associated 
with several syndromes, in particular Down syndrome (DS) [1]. Surgical repair can be accomplished 
with good long-term survival, with an estimated overall survival after 15 years of 88.6% [2]. 
In patients with an AVSD, the AV node and bundle of His are displaced inferiorly [3], predisposing the 
conduction system for injury during surgical repair [4]. Furthermore, functional properties of the 
conduction tissues can be suboptimal and may result in complete heart block [5]. In recent ACC/AHA 
guidelines regular evaluation of the status of AV conduction with ECG and periodic Holter monitoring 
in patients with repaired or palliated AVSD is recommended [5]. 
An incidence of early and late post-operative supraventricular arrhythmias is reported in 9.6% and 
11.7% respectively in patients with a partial AVSD [6] and the reported incidence of pacemaker 
implantation after AVSD correction ranges from 1.3% to 5.0%[6-11]. There is little data on the 
incidence of ventricular arrhythmia and sudden cardiac death (SCD) in AVSD patients [12]. Although 
clinical differences between isolated AVSD and AVSD in the setting of syndromal heart disease are 
overt [1], the difference between DS and non-syndromic patients with regard to conduction and 
rhythm disorders is not well established. Literature suggests that non-syndromic AVSD patients tend 
to have more post-operative arrhythmias, although to date there is no clear evidence about 
differences in post-operative arrhythmias or the need for permanent pacemaker implantation [13]. 
The aims of the current study were 1. To analyse the incidence of post-operative arrhythmias, 
especially late ventricular arrhythmias and SCD, after surgical repair of AVSD and 2. To explore 
potential factors, including DS and type of AVSD, contributing to the risk of rhythm- and conduction 
disorders after surgical repair of AVSD. 
 
 
Methods 
Study Population and Design 
This is a retrospective multicenter study including all AVSD patients who underwent biventricular 
correction between June 1958 and January 2014. Patients were recruited from a surgical database of 
the Center of Congenital Heart Disease Amsterdam-Leiden (CAHAL) that includes all patients who 
have undergone surgical procedures at the Leiden University Medical Center (LUMC) and the 
Amsterdam Academic Medical Center (AMC), the Netherlands. Patients with an unbalanced AVSD 
who underwent univentricular repair and patients with heterotaxy syndrome were excluded from 
the study.   
Data was obtained during follow-up by analyses of medical files, electronic records, 24-hour Holter 
recordings, catheterisation reports, echocardiographic findings and electrocardiograms (ECGs). The 
majority of patients underwent routine follow-up at the paediatric or adult Cardiology departments 
of the LUMC or AMC, some patients underwent routine follow-up at their local hospital. Data, as far 
as obtainable, of these visits were collected.  
Informed consent for retrospective observational studies is not mandatory according to Dutch law, 
provided the results are reported anonymously.  
 
Pre-operative, peri-operative & post-operative data 
Collected data consisted of gender, type of AVSD, associated cardiovascular anomalies, chromosomal 
abnormalities, ECG features and documented arrhythmias or conduction disorders. Treatment of all 
arrhythmias consisting of anti-arrhythmic drug treatment, electrical cardioversion, catheter ablations 
and pacemaker or implantable cardiac defibrillator (ICD) implantation were registered. 
Atrioventricular septal defect was subdivided in complete AVSD (cAVSD; both atrial and ventricular 
shunting) and partial AVSD (pAVSD; atrial or ventricular (intermediate AVSD) shunting). Down 
syndrome was confirmed by chromosomal analysis.  
Collection of ECG-derived data included rhythm, heart rate, PR interval and QRS duration. Paediatric 
ECGs were scored according to normal values matched by age and heart rate [14]. An experienced 
researcher, supervised by a Paediatric Cardiologist and a Cardiologist specialized in grown-up 
congenital heart disease, examined the ECGs. 
Peri-operative data consisted of type of surgical repair (single/double patch) and rhythm after 
cardiopulmonary bypass. As early surgical era may negatively influence survival and risk for 
reoperation, AVSD repairs were divided into two surgical eras: 1958 to 1995 and 1996 to 2014 [2]. 
Post-operative data consisted of post-operative arrhythmias and conduction disorders, early and late 
mortality and cause of death.  
Early mortality was defined as mortality within 30 days after surgery or longer when death occurred 
with the patient still in hospital. Cause of death was classified as cardiac or non-cardiac. Sudden 
cardiac death (SCD) was defined as unexpected death within 1 hour of cardiac symptom onset or 
unwitnessed death.  
 
Rhythm & Conduction disorders 
Arrhythmias documented during the early post-operative period (<30 days) were defined as early 
onset post-operative arrhythmias and arrhythmias documented during the late post-operative period 
(>30 days) as late post-operative arrhythmias. Arrhythmias were classified as either tachy-
arrhythmias or brady-arrhythmias. 
 
Tachy-arrhythmias 
Supraventricular tachycardia was subdivided in atrial flutter (AFL), atrial fibrillation (AF), atrial 
tachycardia (AT), junctional ectopic tachycardia (JET), atrioventricular re-entrant tachycardia (AVRT) 
and AV nodal re-entrant tachycardia (AVNRT).  
Ventricular arrhythmias included ventricular tachycardia (VT) and ventricular fibrillation (VF).  
 
Brady-arrhythmias 
Sino-atrial node (SAN) dysfunction was reported as sinus bradycardia (SB), sick sinus syndrome (SSS), 
SA exit block and atrial or junctional escape rhythm. Rhythm was scored from ECGs and 24-hour 
Holter reports. 
Atrioventricular block (AVB) was categorized as 1st and 2nd degree AVB and complete AVB. Second 
degree AVB was further subdivided in type 1 Wenkebach and type 2 Mobitz block.  
Bundle branch block was subdivided in right or left bundle branch block (RBBB, LBBB) and left 
anterior fascicular block (LAFB).  
 
Pacemaker/ICD implantation 
Pacemaker implantation was subdivided in early post-operative period (<30 days) and late post-
operative period (>30 days) implantation. The indications for pacemaker and ICD therapy were 
documented. 
 
Statistical analysis 
All statistical analyses were performed with IBM SPSS Statistical software (version 20, IBM Corp., 
Armonk, New York, USA). Descriptive statistics were used to describe post-operative arrhythmias and 
the incidence of ICD and pacemaker implantation.  
Univariate Cox regression analyses were performed to evaluate the effect of multiple variables, DS 
(DS versus non-syndromal), type of AVSD (pAVSD versus cAVSD), gender (male versus female) and 
surgical era (before 1996 versus after 1996), on the incidence of arrhythmias and pacemaker 
implantation. The variables DS and type of AVSD were further entered into a stepwise multivariate 
cox regression model to assess their independent value. Some variables were analysed in a time-
dependent Cox model. A P-value of < 0.05 was considered statistical significant.  
 
 
 
 Results 
Patient Characteristics 
Overall, 428 patients underwent biventricular correction at our institute. Patients with other 
syndromes than Down syndrome (n=13) were excluded from further analysis since the numbers of 
events were too low for risk stratification, but an overview of arrhythmia’s that occurred in these 
patients is provided in  appendix 1. 
Therefore, 415 patients were included for further analysis with a mean follow-up duration of 9 years 
(range; <30 days – 47 years) (Figure 1A). Among these, 238 (57%) had a cAVSD and 253 (61%) were 
diagnosed with DS (Table 1). In patients with a cAVSD, DS was present in 206 patients (87% of all 
cAVSD patients). The two most common additional cardiac malformations were patent ductus 
arteriosus (30%) and atrial septal defect type 2 (25%). Other additional cardiac anomalies are listed in 
Table 1. 
Holter monitoring was available in 44 patients (11% of all patients), consisting of 17 patients with DS 
(7% of all patients with DS) and 27 non-syndromic patients (17% of all non-syndromic patients).  
Overall mortality was 10.3%. In-hospital mortality occurred in 5.5% and late mortality in 4.8%. The 
main causes of late cardiac mortality were sudden cardiac death (1.7%) and heart failure (0.5%). 
Eighty-nine patients underwent 128 re-operations. Left atrioventricular valve pathology was the 
most common indication for reoperation, in 53.0%. 
 
Tachy-arrhythmias 
Among the included 415 patients, at least one episode of a SVT was documented in 48 patients 
(11.6%), further subdivided in AF (n=7), AFL (n=8), AVNRT (n=1), AVRT (n=1), JET (n=12), unspecified 
SVT (n=29), and VT or VF in 6 patients (1.9%) (Table 2). Some patients experienced more than one 
type of arrhythmia.  
 
According to analyses of both early and late SVTs, significantly more SVTs occurred in non-syndromic 
patients(P=0.049, HR=1.79; 95% CI= 1.00-3.20). There were no statistically significant associations 
between the occurrence of SVT and gender (p=0.221, HR=1.45; 95% CI= 0.80-2.64), type of AVSD 
(pAVSD vs. cAVSD, p=0.719, HR=0.89; 95% CI= 0.50-1.61) or surgical era (before 1996 vs. after 1996, 
p=0.899, HR=1.04; 95% CI= 0.55-1.99). In Figure 1B the time free interval of SVT is shown for both 
types of AVSD; DS and non-syndromic. 
 
Early post-operative supraventricular arrhythmias 
The majority of SVTs occurred within 30 days after surgical correction (n= 33, 8.0%). In this group, 
there were no significant differences between patients with DS and non syndromic patients 
(p=0.576, HR=1.22; 95% CI= 0.61-2.43). Likewise, there was no significant association between the 
occurrence of early post-operative arrhythmia and gender (p=0.065, HR=2.01; 95% CI= 0.96-4.22), 
type of AVSD (p=0.072, HR=0.50; 95% CI= 0.23-1.06) or surgical era (p=0.992, HR=1.00; 95% CI= 0.50-
2.02). However, in a multiple Cox regression model with DS and type of AVSD, significant more early 
post-operative SVTs occurred in patients with a cAVSD (p=0.005, HR= 3.70; 95% CI= 1.39-7.51) and in 
non-syndromic patients (p=0.022, HR=2.64; 95% CI= 1.15-6.04). 
Electrical cardioversion was performed in 5 patients in the early post-operative period. All other 
patients were treated with anti-arrhythmic drugs. 
 
Late post-operative supraventricular arrhythmias 
Late post-operative SVTs were documented in 15 patients (3.6%). Significant more late SVTs occurred 
in non-syndromic patients as compared to patients with DS (p=0.016, HR=6.38; 95% CI= 1.42-28.71) 
and in pAVSD compared to cAVSD (p=0.045, HR=3.703; 95% CI= 1.03-13.32). No significant 
associations between the occurrence of late post-operative arrhythmia and gender or surgical era 
could be demonstrated. Tetralogy of Fallot was not a risk factor for post-operative arrhythmias.   
Patients experiencing an arrhythmic event in the early post-operative period, included in the model 
as a time-dependent covariate, were not at risk for an event later in life (p=0.486, HR=0.04; 95% CI= 
0.00-296.47). After correction for the presence of DS, no association between type of AVSD and the 
occurrence of late post-operative SVTs could be demonstrated (p=0.762, HR=1.28; 95% CI= 0.260-
6.238). 
Electrical cardioversion was performed in 6 patients in the late post-operative period. Other patients 
were treated with anti-arrhythmic drugs. Four patients underwent catheter ablation for AVRT (n=2) 
and AF (n=2). All patients who underwent catheter ablation were non-syndromic patients with a 
pAVSD. 
 
Post-operative ventricular arrhythmias 
Three VF and 3 VT episodes were documented in 6 patients (1.4%). Two events occurred in patients 
with DS and 3 patients had cAVSD. None of these patients had AVSD – Tetralogy of Fallot. Descriptive 
analyses showed 3 events occurring in the early post-operative period after primary correction and 2 
events occurring in the early post-operative period after re-operation. Two of these patients did not 
survive. Since the number of ventricular events is small, no conventional Cox regression analyses 
were performed. Late life-threatening VT occurred in 2 patients (0.5%, both non-syndromic). One VT 
episode occurred in a patient with a good ventricular function 20 months after his second re-
operation for subvalvular aortic stenosis.  
 
Brady-arrhythmias 
Sinoatrial node dysfunction was reported as SB in 25 patients (6.0%), SSS in 1 patient (0.2%) and 
brady-tachy syndrome in two patients (0.5%). No significant associations between the occurrence of 
sinoatrial node dysfunction and gender, type of AVSD or DS could be demonstrated. 
First degree AVB was present in 97 patients (23.4%), 43 patients had DS and 45 patients had a cAVSD. 
After correction for the AVSD type 1st degree AVB occurred significantly more in non-syndromic 
patients (p=0.008, HR=2.02; 95% CI= 1.21-3.40). No significant difference in gender could be 
demonstrated (p=0.551, HR=0.886; 95% CI= 0.59-1.32). 
Second degree AVB type Wenkebach was reported in 5 patients (1.2%), 2 patients had DS and 4 
patients pAVSD. Second-degree AVB type Mobitz was reported in 13 patients (3.1%), 5 patients with 
DS and 9 patients with pAVSD. At least one episode of early complete AVB was documented in 41 
patients (9.9%), 20 patients with DS and 17 patients with a pAVSD. After correction for the type of 
AVSD significantly more early post-operative complete AVB occurred in non-syndromic patients 
(p=0.016, HR=2.57; 95% CI= 1.19-5.56). Late complete AVB occurred in 3 patients (0.7%). 
Complete RBBB and complete RBBB in combination with LAFB was reported in 44.8% and 26.7% 
respectively. Complete RBBB occurred significantly more frequent in cAVSD, also after correction for 
the presence of DS (p=0.010, HR=1.71; 95% CI= 1.14-2.56). Isolated LAFB and complete LBBB were 
present in 8.9% and 1.2% respectively.  
 
Permanent pacemaker/ICD implantation 
Fifteen patients (3.6%) required permanent pacemaker implantation and no ICD or cardiac 
resynchronisation therapy devices were implanted (Table 3). Down syndrome was present in only 
one patient. The indication for permanent pacemaker implantation was complete AVB in 9 patients. 
In 4 patients complete AVB occurred <30 days after primary correction, in 4 other patients it 
occurred <30 days after a re-operation. One patient spontaneously developed complete AVB 5 years 
after surgery. Non-DS (p=0.008, HR=15.82; 95% CI= 2.04-122.47), pAVSD (p=0.017, HR=6.26; 95% CI= 
1.39-28.28) and re-operation (p=0.007, HR=4.911; 95% CI= 1.54-15.64), as a time-dependent 
covariate, were all independently related to the postoperative need for permanent pacemaker 
implantation. There were no statistically significant associations between permanent pacemaker 
implantation and gender (p=0.545, HR=0.731; 95% CI= 0.27-2.02) or surgical era (p=0.795, HR=0.832; 
95% CI= 0.21-3.34).  
 
  
Discussion 
To our knowledge this is the largest study investigating the incidence and risk factors for rhythm and 
conduction disorders, SCD and pacemaker implantation after AVSD correction with a follow-up of up 
to 47 years. Key findings of this study are; 1) In 11.6% of the patients SVT is reported, 8% in the early 
post-operative period and only 3.6% in the late post-operative period during a mean follow-up 
period of 9 years. 2) Late life-threatening ventricular arrhythmia and SCD occurred in only 0.5% and 
1.7% respectively. 3) Although different forms of conduction disorders are encountered frequently, 
pacemaker implantation was reported in only 3.6%. 4) Non-syndromic AVSD patients have a 
significant higher risk of early and late post-operative SVT’s, 1st degree AVB and early complete AVB. 
5) Partial AVSD, re-operation and non-syndromic AVSD are risk factors for post-operative pacemaker 
implantation after AVSD correction.  
 
Post-operative arrhythmias after AVSD correction 
In the current study, early post-operative SVTs were documented in 8% and late post-operative SVTs 
in only 3.6%, which is lower than reported by El-Najdawi et al. respectively in 9.6% and 11.7% [6]. 
The incidence of early post-operative SVTs in children with congenital heart defects (CHD) is reported 
in 9% - 15% and therefore an AVSD or correction of an AVSD does not seem to convey an additional 
risk for early post-operative SVTs [15]. However, significant more late SVTs were documented in 
patients with a pAVSD compared to cAVSD. This might due to insufficiency of the left AV valve, which 
mostly occurs in patients with a pAVSD, and its effect on the atria [29]. In adults with CHD SVTs, 
including AF and AFL, are reported in 15%, and these are related to the severity of the underlying 
cardiac defect, its surgical treatment, age and the development of heart failure [16-18]. In our study 
population late AF and AFL occurred in only 2.4%, unfortunately there is no data on late AF and AFL 
after AVSD correction in the current literature to compare this finding. However, this is lower than 
the reported incidence after repair in other CHD populations, such as tetralogy of Fallot and 
secundum atrial septal defect [16]. The lower incidence of late post-operative AF and AFL in our 
population might due to a relatively short mean follow-up duration.  
 
Ventricular arrhythmia in the early post-operative period after surgical correction or reoperations 
occurred in 1.2%. This is lower than the incidence of early post-operative ventricular arrhythmias in 
patients with CHD, which is reported in 2.1% in children and 5.0% in adults [19, 20].  
 
Sudden cardiac death and late ventricular arrhythmias 
Heart failure and SCD are the major causes of late death in postoperative patients with CHD [21]. 
Large cohort studies indicate that late SCD can occur in CHD patients with different underlying 
defects [22]. In our cohort SCD and heart failure were the main causes of late death. We found a low 
incidence of life threatening ventricular arrhythmias and SCD beyond the early postoperative period. 
Although there is no other literature data in AVSD patients for comparison, our results are in contrast 
to the higher incidences of ventricular arrhythmia and SCD in large CHD cohort studies [12, 22]. Our 
findings indicate that postoperative AVSD patients form a low risk group for SCD.  
 
Conduction disorders and pacemaker implantation after AVSD correction 
Atrioventricular conduction disturbances varying from 1st degree to complete AVB are described in 
patients with an AVSD [9, 23, 24]. Late complete AVB is reported in 0.5% of the patients by Lin et al 
[25], which is in line with our results. Although 1st degree AVB and bundle branch blocks were 
encountered quite frequently in our population, second degree and spontaneous complete AVB in 
the late post-operative period are rare. Only 3.7% of the patients in our population required 
pacemaker implantation. This is an average of what is reported in the literature after AVSD 
correction [6-11] and is in a similar range of pacemaker implantation incidence after mitral valve 
surgery in adults with acquired heart disease: 2.6% - 6% [26-28]. Significant less pacemakers were 
implanted in patients with DS as compared to non-syndromic patients in our study. Lange et al. 
reported a pacemaker implantation rate of 5.1% in patients with DS and 6.3% in non-syndromic 
patients after AVSD correction [11].  
Re-operation and pAVSD were associated with a significant higher risk of pacemaker implantation. 
Left AV valve pathology is the main indication for re-operation in AVSD patients [2, 29-31]. Extensive 
abnormalities of the AV valves are more frequently seen in patients without DS, and more often in 
combination with a pAVSD [11, 32, 33]. This renders repair of the AV valves more challenging and 
increases the risk of recurrence of left AV valve pathology and reoperation and therefore risk of 
damage to the AV-node necessitating PM-implantation. Several studies have shown a lower risk for 
reoperation in patients with DS and a cAVSD [11, 32, 34]. 
 
Influence of Down syndrome 
Data on the influence of DS on cardiac conduction and arrhythmias is scarce [35]. According to our 
results, non-syndromic patients had a significant higher risk of early and late post-operative SVTs. 
Our findings are in line with the results published by Dunlop et al., but contradictory to the early 
post-operative outcomes published by Desai et al., who reported no difference in SVTs in patients 
with and without DS [13, 36].  
There is no data about possible differences in the development of the conduction system between 
DS AVSD vs. non-syndromic AVSD. However, development of the AV node and the ventricular 
conduction system in DS AVSD is different compared to normal [37]. Furthermore, an aberrant 
development of the AV septum in DS, even in the absence of AVSD is observed [38, 39], suggesting 
structural differences in the AV node area as compared to non-syndromic hearts. Whether this 
relates to the findings in the current study is as yet unclear.  
Another factor influencing the lower incidence of documented arrhythmias in DS might also relate to 
underreporting of complaints by DS patients, either due to their mild to moderate impaired mental 
functioning or due to communication problems. Furthermore, not all patients had a Holter recording, 
as in our cohort, the performance of a Holter recording was at the discretion of the physician. This 
may have influenced our diagnostic work-up in patients with Down-syndrome [40]. 
 
 
Study limitations 
This study has limitations inherent to any retrospective study. Data collection was limited to data 
available in medical and electronic files. As stated above, incidence of arrhythmias might be 
underestimated in DS patients, influencing our results. Patients who are doing well after surgery, or 
complain less, were potentially monitored less rigorously. This may result in less additional 
diagnostics as Holter monitoring, and thus in underreporting of events. Not al arrhythmias were 
documented on ECG and not all patients had ECGs in their medical file, this may result in less 
accurate description of the arrhythmias. Furthermore, some events may occur later during follow-up 
and therefore may be missed in the current study.  
 
Clinical application & conclusions 
There is a good long-term survival after biventricular AVSD correction and the incidence of life-
threatening ventricular arrhythmias and SCD is low. Furthermore, post-operative arrhythmias do not 
have a high incidence after AVSD correction. On the other hand, conduction disorders of some 
degree are encountered frequently, but there is a low incidence of pacemaker implantation. Rhythm 
and conduction disorders may occur at any time during follow-up. Non-syndromic patients have a 
significant higher risk for early and late post-operative SVT and early complete AVB. Risk factors for 
post-operative pacemaker implantation are pAVSD, re-operation and non-syndromic AVSD. In our 
study cohort Holter recordings seem to be underutilized, especially in DS patients. Periodic Holter 
monitoring should be performed, according to the American guidelines [5], after AVSD correction to 
prevent potential underreporting. 
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Tables 
Table 1. Patient characteristics  
 Total n=415 cAVSD n=238 pAVSD  
n=177 
p-value  
cAVSD vs. pAVSD 
 
Gender M/F 193/222  113/125  80/97  0,645   
Isolated AVSD  165 35 130 < 0,001 
Down Syndrome  253  206  47 < 0,001 
Additional cardiac 
anomalies: 
PDA 
ASD type II 
VSD  
PLSCV 
ToF 
CoA 
BPV  
BAV 
AS  
SubAS 
SupraAS 
 
 
126 
104 
41 
27 
18 
10 
9 
4 
0 
2 
2 
 
 
111 
74 
2 
16 
17 
5 
7 
2 
- 
- 
- 
 
 
15 
30 
39 
11 
1 
5 
2 
2 
- 
2 
2 
 
 
< 0,001 
0,001  
< 0,001 
0,836 
0,001 
0,634 
0,107 
0,765 
 
0,100 
0,100  
Mean age at repair (yrs) 3,03 ± 5,88 
 
0,75 ± 1,37  6,11 ± 
7,89 
< 0,001 
Early surgical era  
(1958-1995) 
Late surgical era  
(1996 – 2013) 
161  
 
254  
76 
 
162 
85 
 
92 
0,001 
 
0,001 
Double patch technique  
 
Single patch technique  
 
Unknown 
229 
 
184 
 
2 
221 
 
15 
8 
 
169  
< 0,001 
 
< 0,001 
 
AS= Aortic stenosis, ASD= Atrial septal defect, BAV= Bicuspid aortic valve, BPV= Bicuspid pulmonary 
valve, cAVSD= Complete atrioventricular septal defect, CoA= Coarctation aortae, F= Female, M= 
Male, pAVSD= Partial atrioventricular septal defect, PDA= Patent ductus arteriosis, PLSVC= Persistent 
left superior vena cava, ToF= Tetralogy of Fallot, VSD= Ventricular septal defect, yrs.= Years  
 
 
 
  
 
Table 2. Early and late post-operative arrhythmias  
  
cAVSD= Complete atrioventricular septal defect, DS= Down syndrome, NS= Non-syndromic, 
pAVSD= Partial atrioventricular septal defect, SVT= Supraventricular tachycardia, VF= Ventricular 
fibrillation, VT= Ventricular tachycardia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 cAVSD (n=23) pAVSD (n=25) 
 
DS (n=18) NS (n=5) DS (n=3) NS (n=22) 
Overall  
post-operative 
arrhythmias 
SVT  
(n=48) 
18 5 3 22 
VT/VF 
(n=6) 
2 1 0 3 
Early post-operative 
arrhythmias 
SVT 
(n=33) 
16 (88,9%) 4 (80%) 3 (100%) 10 (45,5%) 
 
Late post-operative  
arrhythmias 
SVT 
(n=15) 
 
2 (11,1%) 1 (20%) 0 (0%) 12 (54,5%) Commented [RK1]: In response to R3Q4 
  
 
 
Table 3. Pacemaker implantations after AVSD correction 
AVB= Atrioventricular block, cAVSD= Complete atrioventricular septal defect, DS= Down syndrome, F= 
Female, M= Male, pAVSD= Partial atrioventricular septal defect, PM= Pacemaker, SSS= Sick sinus 
syndrome 
 
 
 
Gender Type of 
AVSD 
DS PM indication(s) Re-
operation 
(N=) 
Time to PM 
implantation 
F pAVSD  No Complete AVB Yes (3) < 30 Days after 
re-operation 
F pAVSD No Complete AVB No 5 Years after 
correction 
M pAVSD  No AF with slow ventricle reponse Yes (1) 20 Years after 
correction 
F cAVSD Yes SSS No 19 Years after 
correction 
M pAVSD  No 2nd AVB Mobitz No 26 Years after 
correction 
M pAVSD  No 2nd AVB Mobitz No 1 Year after 
correction 
M pAVSD  No Complete AVB Yes (2) < 30 Days after 
re-operation 
F cAVSD No Complete AVB No < 30 Days after 
correction 
F pAVSD  No Complete AVB Yes (2) < 30 Days after 
re-operation 
M pAVSD  No Complete AVB Yes (5) < 30 Days after 
re-operation 
M pAVSD  No Complete AVB Yes (2) < 30 Days after 
correction 
F pAVSD  No Complete AVB , 2nd AVB 
Mobitz, SSS 
No < 30 Days after 
correction 
F pAVSD  No Brady-tachy syndrome No 32 Years after 
correction 
M pAVSD  No Complete AVB Yes (4) < 30 Days after 
correction 
M pAVSD  No Brady-tachy syndrome No 35 Years after 
correction 
 
 
Figures 
Figure 1A + 1B Inclusion of patients and time free of SVT 
 AVSD patients  
(1958-2014)
N = 523
Inclusion 
N=415
cAVSD 
N=238
Non syndromal  
N=32
DS
N=206 
pAVSD 
N=177
Non syndromal  
N=130
DS 
N=47
Exclusion 
N=108
1A Inclusion of patients 
 
1B Time free of SVT in 4 different groups; cAVSD-DS (green), cAVSD-ND (blue), pAVSD-DS (purple) and pAVSD-ND (yellow). Percentage free of SVT and the 
remaining cases are provided above. 
Significant less SVT occurred in the pAVSD-DS (p=0.017) and cAVSD-DS (p=0.011) group compared to cAVSD-ND group.  
cAVSD= Complete atrioventricular septal defect, DS= Down syndrome, NS= Non-syndromic, pAVSD= Partial atrioventricular septal defect, SVT= 
Supraventricular tachycardie 
Appendix 1 
 
Supplemental data 
 
Table 1 Type of syndrome and incidence of SVT/VT/VF/ PM-implantation 
 
Type of syndrome N= SVT VT/VF PM 
Non-sydromic 162 27 4 14 
Down syndrome 253 21 2 1 
Other syndromes: 13 4 2 1 
22q11 deletion 1 1 - - 
3p deletion 1 - - - 
Bardet-Biedl 
syndrome 
1 - 1 - 
CHARGE syndrome 2 1 - 1 (SSS/ 3rd degree 
AVB) 
Ellis van Creveld 
syndrome 
2 - - - 
Mohr syndrome 1 - - - 
Noonan syndrome 2 1 - - 
Unknown syndrome 3 1 1 - 
 
